Literature DB >> 22763213

Intimal thickness associated with endothelial dysfunction in human vein grafts.

Fan Dong Li1, Kevin W Sexton, Kyle M Hocking, Michael J Osgood, Susan Eagle, Joyce Cheung-Flynn, Colleen M Brophy, Padmini Komalavilas.   

Abstract

BACKGROUND: Intimal hyperplasia is a complex process thought to be initiated by injury and is the leading cause of vein graft failure. In the present investigation, we hypothesized that the basal intimal thickness in the human saphenous vein is a predictor of endothelial dysfunction and, potentially, intimal hyperplasia.
METHODS: Human saphenous veins were obtained during coronary artery bypass surgery. The segments were contracted with phenylephrine and relaxed with carbachol to determine the endothelial-dependent relaxation. The vein segments were fixed in 10% buffered formalin and grown for 14 d in high-serum culture and then fixed in formalin. The fixed tissues were stained with Verhoeff-Van Gieson, and the average intimal and medial thicknesses were calculated using light microscopy and a computerized image analysis system.
RESULTS: The human saphenous veins displayed varying amounts of basal intimal thickness (range 18.80-241.3 μm). The endothelial-dependent relaxation of the veins was highly variable, with values ranging from 0% to 27.59%. Human saphenous veins with a basal intimal thickness greater than 120 μm had significantly less endothelial-dependent relaxation (8.90% ± 6.32%) than those with a basal intimal thickness less than 120 μm (21.97% ± 10.64%). Endothelial dysfunction correlated with a basal intimal thickness greater than 120 μm (P = 0.02). The basal intimal thickness also correlated with increased intimal thickness after 14 d in organ culture (P = 0.0001).
CONCLUSIONS: A basal intimal thickness greater than 120 μm is a predictor of endothelial dysfunction. Also, because a greater basal intimal thickness correlated with an increased intimal thickness after organ culture, the basal intimal thickness might predict vein graft failure owing to intimal hyperplasia. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22763213      PMCID: PMC3515722          DOI: 10.1016/j.jss.2012.06.017

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  26 in total

Review 1.  Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response.

Authors:  E Allaire; A W Clowes
Journal:  Ann Thorac Surg       Date:  1997-02       Impact factor: 4.330

2.  Pre-bypass quality assessment of the long saphenous vein wall with ultrasound and histology.

Authors:  A D Giannoukas; N Labropoulos; G Stavridis; D Bailey; B Glenville; A N Nicolaides
Journal:  Eur J Vasc Endovasc Surg       Date:  1997-07       Impact factor: 7.069

3.  Endothelium-dependent vasorelaxations in response to aggregating platelets are impaired in reversed vein grafts.

Authors:  K Komori; P Gloviczki; R G Bourchier; V M Miller; P M Vanhoutte
Journal:  J Vasc Surg       Date:  1990-08       Impact factor: 4.268

4.  Histological study of arterial and venous grafts before their use in aortocoronary bypass surgery.

Authors:  Maria Kanellaki-Kyparissi; Kokkona Kouzi-Koliakou; George Marinov; Victor Knyazev
Journal:  Hellenic J Cardiol       Date:  2005 Jan-Feb

Review 5.  Endothelial cell injury in cardiovascular surgery.

Authors:  E D Verrier; E M Boyle
Journal:  Ann Thorac Surg       Date:  1996-09       Impact factor: 4.330

Review 6.  Long-term results of coronary bypass surgery. Analysis of 1698 patients followed 15 to 20 years.

Authors:  G M Lawrie; G C Morris; N Earle
Journal:  Ann Surg       Date:  1991-05       Impact factor: 12.969

Review 7.  Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention.

Authors:  J G Motwani; E J Topol
Journal:  Circulation       Date:  1998-03-10       Impact factor: 29.690

8.  Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media.

Authors:  P R Mosse; G R Campbell; Z L Wang; J H Campbell
Journal:  Lab Invest       Date:  1985-11       Impact factor: 5.662

9.  Saphenous vein angioscopy: a valuable method to detect unsuspected venous disease.

Authors:  C M Sales; M L Marin; F J Veith; W D Suggs; T F Panetta; K R Wengerter; R E Gordon
Journal:  J Vasc Surg       Date:  1993-08       Impact factor: 4.268

10.  Human saphenous vein organ culture: a useful model of intimal hyperplasia?

Authors:  K E Porter; K Varty; L Jones; P R Bell; N J London
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-01       Impact factor: 7.069

View more
  18 in total

1.  Preservation solution impacts physiologic function and cellular viability of human saphenous vein graft.

Authors:  Eric S Wise; Kyle M Hocking; Susan Eagle; Tarek Absi; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  Surgery       Date:  2015-05-21       Impact factor: 3.982

2.  Pressure control during preparation of saphenous veins.

Authors:  Fan Dong Li; Susan Eagle; Colleen Brophy; Kyle M Hocking; Michael Osgood; Padmini Komalavilas; Joyce Cheung-Flynn
Journal:  JAMA Surg       Date:  2014-07       Impact factor: 14.766

3.  Adenosine triphosphate as a molecular mediator of the vascular response to injury.

Authors:  Christy M Guth; Weifung Luo; Olukemi Jolayemi; Kalyan S Chadalavada; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  J Surg Res       Date:  2017-03-31       Impact factor: 2.192

4.  Brilliant blue FCF as an alternative dye for saphenous vein graft marking: effect on conduit function.

Authors:  Igor V Voskresensky; Eric S Wise; Kyle M Hocking; Fan Dong Li; Michael J Osgood; Padmini Komalavilas; Colleen Brophy; Joyce Cheung-Flynn
Journal:  JAMA Surg       Date:  2014-11       Impact factor: 14.766

5.  Unregulated saphenous vein graft distension decreases tissue viscoelasticity.

Authors:  Eric S Wise; Kyle M Hocking; Brian C Evans; Craig L Duvall; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  Perfusion       Date:  2017-03-09       Impact factor: 1.972

6.  Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro.

Authors:  Daniel J Wong; Daniel Y Lu; Clinton D Protack; Go Kuwahara; Hualong Bai; Nirvana Sadaghianloo; George Tellides; Alan Dardik
Journal:  J Vasc Surg       Date:  2014-10-24       Impact factor: 4.268

7.  Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.

Authors:  Michael J Osgood; Kevin Sexton; Igor Voskresensky; Kyle Hocking; Jun Song; Padmini Komalavilas; Colleen Brophy; Joyce Cheung-Flynn
Journal:  J Vasc Surg       Date:  2016-08       Impact factor: 4.268

8.  Tissue-engineered vascular grafts created from human induced pluripotent stem cells.

Authors:  Sumati Sundaram; Jennifer One; Joshua Siewert; Stephan Teodosescu; Liping Zhao; Sashka Dimitrievska; Hong Qian; Angela H Huang; Laura Niklason
Journal:  Stem Cells Transl Med       Date:  2014-11-05       Impact factor: 6.940

Review 9.  Vein graft failure.

Authors:  Christopher D Owens; Warren J Gasper; Amreen S Rahman; Michael S Conte
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

10.  Traditional graft preparation decreases physiologic responses, diminishes viscoelasticity, and reduces cellular viability of the conduit: A porcine saphenous vein model.

Authors:  Eric S Wise; Kyle M Hocking; Weifeng Luo; Daniel L Feldman; Jun Song; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  Vasc Med       Date:  2016-05-23       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.